loading...| Preferred Name | Iodine I-125 | |
| Synonyms |
Iodine I-125 Iodine I 125 IODINE I-125 125-Iodine I-125 Iodine 125 |
|
| Definitions |
A radioactive isotope of iodine, a nonmetallic element of the halogen group. With a half-life of 60 days, iodine 125 occurs naturally and can be produced artificially. This agent has both therapeutic and diagnostic uses, particularly in thyroid disease. (NCI04) |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1841 |
|
| Accepted_Therapeutic_Use_For |
Prostate Cancer |
|
| CAS_Registry |
17144-19-3 |
|
| code |
C1841 |
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
| Contributing_Source |
CTRP FDA |
|
| DEFINITION |
A radioactive isotope of iodine, a nonmetallic element of the halogen group. With a half-life of 60 days, iodine 125 occurs naturally and can be produced artificially. This agent has both therapeutic and diagnostic uses, particularly in thyroid disease. (NCI04) |
|
| Display_Name |
Iodine I-125 |
|
| FDA_UNII_Code |
GVO776611R |
|
| FULL_SYN |
Iodine I-125 Iodine I 125 IODINE I-125 125-Iodine I-125 Iodine 125 |
|
| label |
Iodine I-125 |
|
| Legacy Concept Name |
Iodine_I_125 |
|
| NCI_Drug_Dictionary_ID |
43241 |
|
| PDQ_Closed_Trial_Search_ID |
43241 |
|
| PDQ_Open_Trial_Search_ID |
43241 |
|
| Preferred_Name |
Iodine I-125 |
|
| prefixIRI |
Thesaurus:C1841 |
|
| Semantic_Type |
Pharmacologic Substance Element, Ion, or Isotope |
|
| UMLS_CUI |
C0796396 |
|
| subClassOf |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://purl.bioontology.org/ontology/PDQ/CDR0000043241 | PDQ | LOOM | |
| http://purl.bioontology.org/ontology/NDFRT/N0000146517 | NDFRT | LOOM | |
| https://go.drugbank.com/drugs/DB14804 | MDM | LOOM | |
| http://purl.bioontology.org/ontology/VANDF/4018182 | VANDF | LOOM | |
| http://purl.obolibrary.org/obo/NCIT_C1841 | BERO | LOOM |